VERACYTE, INC. (VCYT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2022-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2022-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2022-12-31..
Borrowing debt
Overview →Financial period ending 2022-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2022-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2022-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2022-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.16B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $1.16B | (m) |
| 2022-09-30 | (m) | (m) | $1.19M | (m) | (m) | (m) | $1.13B | (m) |
| 2022-06-30 | (m) | (m) | $1.13M | (m) | (m) | (m) | $1.14B | (m) |
| 2022-03-31 | (m) | (m) | $1.08M | (m) | (m) | (m) | $1.17B | (m) |
| 2021-12-31 | (m) | (m) | $1.13M | $0.00 | (m) | (m) | $1.19B | (m) |
| 2021-09-30 | (m) | (m) | (m) | $1.07M | (m) | (m) | $1.19B | (m) |
| 2021-06-30 | (m) | (m) | (m) | $917.00K | (m) | (m) | $1.03B | (m) |
| 2021-03-31 | (m) | (m) | (m) | $863.00K | (m) | (m) | $1.03B | (m) |
| 2020-12-31 | (m) | (m) | (m) | $810.00K | (m) | (m) | $457.16M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $756.00K | (m) | (m) | $454.15M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $801.00K | (m) | (m) | $256.74M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $748.00K | (m) | (m) | $267.10M | (m) |
| 2019-12-31 | (m) | (m) | $0.00 | $694.00K | (m) | (m) | $275.21M | (m) |
| 2019-09-30 | (m) | (m) | $0.00 | $639.00K | (m) | (m) | $260.31M | (m) |
| 2019-06-30 | (m) | (m) | $0.00 | $585.00K | (m) | (m) | $252.38M | (m) |
| 2019-03-31 | (m) | (m) | $0.00 | $12.85M | (m) | (m) | $123.54M | (m) |
| 2018-12-31 | (m) | (m) | $1.36M | $23.93M | (m) | (m) | $120.64M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $25.19M | (m) | (m) | $119.08M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $25.10M | (m) | (m) | $65.46M | (m) |
| 2018-03-31 | (m) | (m) | (m) | $25.02M | (m) | (m) | $71.19M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $24.94M | (m) | (m) | $78.67M | (m) |
| 2017-09-30 | (m) | (m) | (m) | $25.00M | (m) | (m) | $83.66M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $24.97M | (m) | (m) | $88.35M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $24.94M | (m) | (m) | $92.61M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $24.92M | (m) | (m) | $101.03M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $24.89M | (m) | (m) | $69.65M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $24.67M | (m) | (m) | $74.83M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $24.45M | (m) | (m) | $84.27M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $5.03M | (m) | (m) | $75.28M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $5.00M | (m) | (m) | $80.85M | (m) |
| 2015-06-30 | (m) | (m) | (m) | $4.97M | (m) | (m) | $82.50M | (m) |
| 2015-03-31 | (m) | (m) | (m) | $4.95M | (m) | (m) | $55.06M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $4.92M | (m) | (m) | $64.84M | (m) |
| 2014-09-30 | (m) | (m) | $1.42M | $3.59M | (m) | (m) | $71.81M | (m) |
| 2014-06-30 | (m) | (m) | $940.00K | $4.03M | (m) | (m) | $67.75M | (m) |
| 2014-03-31 | (m) | (m) | $467.00K | $4.47M | (m) | (m) | $72.45M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $4.90M | (m) | (m) | $79.63M | (m) |
| 2013-09-30 | (m) | (m) | (m) | $4.86M | (m) | (m) | $23.57M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |